-
In the Medicare population, obesity was not associated with mortality, except for those with a BMI of at least 35. However, both overweight and obesity were associated with new or worsening disability within 2 years.
-
In a population-based study using hospital discharge diagnosis codes, patients with sleep apnea who underwent knee arthroplasty or open abdominal procedures were more likely to require invasive mechanical ventilation and to be diagnosed with aspiration pneumonia or ARDS than were matched patients without sleep apnea. Knee-replacement patients, but not those undergoing laparotomy, also were more likely to be diagnosed with pulmonary embolism.
-
A third dipetdyl peptidase-4 (dpp-4) inhibitor has been approved by the FDA. Linagliptin follows sitagliptin and saxagliptin to the market. It is marketed by Boehringer Ingelheim as Tradjenta.
-
-
Important differences in adherence to antihypertensive drug therapy occurred depending on the drug class prescribed with the lowest adherence noted to occur with diuretics and beta-blocker therapy and the highest adherence was observed with ARB or ACI therapy.
-
In this double-blind protocol, normal-weight (body mass index [BMI] 19.0-24.9 kg/m2) and obese (BMI 30.0-39.9 kg/m2) women with regular periods and normal ovarian ultrasound took one of two types of oral contraceptives (OCPs): either 21-day monophasic pills with 20 mcg ethinyl estradiol/100 mcg levonorgestrel or 30 mcg ethinyl estradiol/150 mcg levonorgestrel.
-
In this issue: ACEI/ARB therapy for AS; safety alert issued for dronedarone; statins and cancer risk; nesiritide and heart failure; and FDA actions.
-
-
Due to the frequent identification of metastatic disease at diagnosis and its high associated mortality, ovarian cancer has been the persistent focus of many screening efforts.
-
Two recent studies have re-energized discussion regarding the safety of ultrasound a subject that pops up periodically and then disappears until a new study surfaces.